BICLUSTER_ID : UPREG-14
PATHOGENS /2/ : streptococcus pneumoniae,ehrlichia chaffeensis
TARGETS /53/ : TGFBR2, ACPP, LCN2, NDUFA3, NDUFB8, NDUFV1, CDC25B, NDUFA1, NDUFB5, NDUFS8, NDUFS1, NDUFA8, UQCRC1, NFKB1, PET112L, NDUFS6, ABCC1, CCL8, PPARG, PDGFRA, NDUFS2, NDUFAB1, SERPINE1, NDUFB2, ICAM1, NDUFA12, NDUFC1, NDUFB10, PLA2G4A, ANXA3, NDUFV2, NDUFS5, NDUFA13, SDHB, BCL2, SERPINB2, PLAU, MTHFD2, AMPD3, SLC7A1, PIM1, DNMT1, ADA, NDUFB3, STAT1, NDUFA9, ALOX5, WARS, TAP1, NDUFA4, NDUFB6, ITGA2B, IL6
Gene SetLeading Edge Genes
CORUM RESPIRATORY CHAIN COMPLEX I HOLOENZYME MITOCHONDRIALNDUFA13, NDUFS5, NDUFV2, NDUFA3, NDUFB8, NDUFV1, NDUFA1, NDUFB5, NDUFS1, NDUFS8, NDUFA8, NDUFB3, NDUFS6, NDUFA9, NDUFA4, NDUFS2, NDUFB6, NDUFAB1, NDUFB2, NDUFB11, NDUFA12, NDUFB10, NDUFC1
MOOTHA VOXPHOSBCS1L, NDUFA3, UQCR, NDUFB8, ATP5H, NDUFB5, NDUFS1, UQCRFS1, NDUFS8, COX11, NDUFA8, UQCRC1, ATP5O, PET112L, NDUFS6, ATP5G1, ATP5J, COX15, ATP5E, NDUFS2, NDUFAB1, COX6C, NDUFB2, UQCRC2, ATP5F1, SURF1, NDUFC1, COX5A, NDUFS5, SDHB, ATP5C1, COX5B, NDUFB3, NDUFA9, COX4I1, UQCRB, COX7A2, NDUFA4, COX6A1, NDUFB6, COX7C, ATP5B
NETPATH IL 1 PATHWAY UPANXA3, RHOB, ACPP, LCN2, NFKBIE, BUB1, HBEGF, SERPINB2, MTHFD2, NFKBIA, LOX, PRKCD, AMPD3, TNFRSF11B, MT2A, CXCL2, DNMT1, PTX3, NFKB1, BIRC3, CXCL1, WARS, CCL8, IL6, SERPINE1, ICAM1
NETPATH IL 2 PATHWAY DOWNSSBP2, TGFBR2, LIMS1, LOH11CR2A, UCP2, TBC1D8, PASK, PTPN6, TAX1BP3, CDC25B, RERE, LSP1, RGS10, SLC7A1, MT2A, EVL, RPS6KA3, ADA, SORL1, BIRC3, LITAF, LIMK2, TAP1, PBXIP1, ELF1, FYB, AHNAK, CRIP1, ITGA2B
NETPATH IL 6 PATHWAY UPGADD45B, LOH11CR2A, HBEGF, MAP3K8, NMI, TNFRSF11B, PIM1, FOS, STAT1, CEBPD, ABCC1, CXCL1, CEBPB, PPARG, PDGFRA, MAFF, IRF1, PRDM1
NCI ATF2 PATHWAYDUSP5, BCL2, PDGFRA, PLAU, IL6, ATF3, FOS, DUSP8, CCNA2
NETPATH IL 5 PATHWAYPTPN6, PLA2G4A, STAT1, NFKBIA, RPS6KA1, SDCBP, ALOX5, CBL
NCI COLLAGEN ADHESION VIA ALPHA 2 BETA 1 GLYCOPROTEIN
ITO PTTG1 TARGETS UP
CORUM UBIQUITIN E3 LIGASE NFKBIA FBXW11 CUL1 SKP1A
MAHAJAN RESPONSE TO IL1A UP
WEINMANN ADAPTATION TO HYPOXIA DN
REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS
LINDSTEDT DENDRITIC CELL MATURATION B
HUANG FOXA2 TARGETS DN
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS YELLOW UP
COATES MACROPHAGE M1 VS M2 UP
NETPATH IL 7 PATHWAY UP
MISHRA CARCINOMA ASSOCIATED FIBROBLAST UP
WANG SMARCE1 TARGETS UP
NAKAYAMA FRA2 TARGETS
JEON SMAD6 TARGETS UP
LIN SILENCED BY TUMOR MICROENVIRONMENT
HASINA NOL7 TARGETS UP
KLEIN PRIMARY EFFUSION LYMPHOMA DN
SCIBETTA KDM5B TARGETS UP
ALCALA APOPTOSIS
BOYAULT LIVER CANCER SUBCLASS G56 DN
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
NCI HIF1 TFPATHWAY
COULOUARN TEMPORAL TGFB1 SIGNATURE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
MARTINEZ RB1 AND TP53 TARGETS UP
HAN SATB1 TARGETS DN
MCBRYAN PUBERTAL BREAST 3 4WK UP
CERVERA SDHB TARGETS 1 UP
NCI REG GR PATHWAY
CORUM PRB2/P130-MULTIMOLECULAR COMPLEX RB2 E2F5 HDAC1 SUV39H1 P300
SENGUPTA NASOPHARYNGEAL CARCINOMA UP
DEBOSSCHER NFKB TARGETS REPRESSED BY GLUCOCORTICOIDS
AMIT EGF RESPONSE 120 HELA
REACTOME APOPTOSIS
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP
KYNG DNA DAMAGE BY UV
GAJATE RESPONSE TO TRABECTEDIN UP
BIOCARTA TCR PATHWAY
HELLER SILENCED BY METHYLATION UP
WOOD EBV EBNA1 TARGETS DN
LAU APOPTOSIS CDKN2A UP
GOZGIT ESR1 TARGETS DN
BIOCARTA CARDIACEGF PATHWAY
NCI P38ALPHABETAPATHWAY
BROWNE HCMV INFECTION 14HR UP
SASSON RESPONSE TO GONADOTROPHINS DN
BERENJENO TRANSFORMED BY RHOA UP
CORUM REL-MAP3K8-RELA-TNIP2-PAPOLA COMPLEX
VERHAAK AML WITH NPM1 MUTATED UP
SPIRA SMOKERS LUNG CANCER UP
ST TUMOR NECROSIS FACTOR PATHWAY
TIAN TNF SIGNALING VIA NFKB
CHASSOT SKIN WOUND
CHARAFE BREAST CANCER BASAL VS MESENCHYMAL DN
KEGG APOPTOSIS
DODD NASOPHARYNGEAL CARCINOMA DN
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
HOSHIDA LIVER CANCER SURVIVAL UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
MISSIAGLIA REGULATED BY METHYLATION UP
CHIARADONNA NEOPLASTIC TRANSFORMATION CDC25 DN
ZHAN MULTIPLE MYELOMA CD1 AND CD2 DN
DAZARD RESPONSE TO UV NHEK DN
GEORGANTAS HSC MARKERS
RHODES UNDIFFERENTIATED CANCER
BROWNE HCMV INFECTION 12HR UP
TARTE PLASMA CELL VS PLASMABLAST DN
ONDER CDH1 TARGETS 1 UP
BIOCARTA BCR PATHWAY
BOYLAN MULTIPLE MYELOMA D DN
IWANAGA CARCINOGENESIS BY KRAS PTEN DN
CORUM ITGA2B-ITGB3-FN1-TGM2 COMPLEX
KRIGE RESPONSE TO TOSEDOSTAT 24HR UP
KEGG SMALL CELL LUNG CANCER
VERNELL RETINOBLASTOMA PATHWAY UP
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
MULLIGHAN MLL SIGNATURE 2 UP
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
NCI LYSOPHOSPHOLIPID PATHWAY
SCHAVOLT TARGETS OF TP53 AND TP63
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLACK UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
NETPATH IL 6 PATHWAY
DIRMEIER LMP1 RESPONSE LATE UP
GALI TP53 TARGETS APOPTOTIC UP
AMIT EGF RESPONSE 20 HELA
NETPATH IL 3 PATHWAY
BIOCARTA NTHI PATHWAY
MARZEC IL2 SIGNALING UP
TANG SENESCENCE TP53 TARGETS DN
LINDGREN BLADDER CANCER CLUSTER 2A DN
ENK UV RESPONSE EPIDERMIS DN
FRIDMAN SENESCENCE UP
CROMER TUMORIGENESIS UP
BLALOCK ALZHEIMERS DISEASE UP
KEGG PANCREATIC CANCER
FERRARI RESPONSE TO FENRETINIDE UP
DACOSTA LOW DOSE UV RESPONSE VIA ERCC3 XPCS UP
AMUNDSON POOR SURVIVAL AFTER GAMMA RADIATION 2G
AMUNDSON POOR SURVIVAL AFTER GAMMA RADIATION 8G
SANA RESPONSE TO IFNG UP
BENPORATH CYCLING GENES
CASTELLANO NRAS TARGETS DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS DN
LUI THYROID CANCER CLUSTER 1
NCI ENDOTHELINPATHWAY
WU HBX TARGETS 1 UP
KEGG PARKINSONS DISEASE
WANG BARRETTS ESOPHAGUS DN
IGARASHI ATF4 TARGETS DN
BENPORATH ES CORE NINE CORRELATED
HOEBEKE LYMPHOID STEM CELL UP
MOOTHA MITOCHONDRIA
DOANE BREAST CANCER ESR1 DN
MULLIGHAN MLL SIGNATURE 1 UP
WANG METHYLATED IN BREAST CANCER
HOLLMAN APOPTOSIS VIA CD40 DN
REACTOME TOLL RECEPTOR CASCADES
ODONNELL TARGETS OF MYC AND TFRC UP
BREDEMEYER RAG SIGNALING VIA ATM NOT VIA NFKB UP
KENNY CTNNB1 TARGETS UP
ONDER CDH1 TARGETS 1 DN
CHIANG LIVER CANCER SUBCLASS PROLIFERATION UP
BIOCARTA IL7 PATHWAY
NCI SMAD2 3NUCLEARPATHWAY
LINDSTEDT DENDRITIC CELL MATURATION C
OSMAN BLADDER CANCER UP
ELVIDGE HYPOXIA BY DMOG UP
BROWNE HCMV INFECTION 48HR UP
VANTVEER BREAST CANCER METASTASIS DN
BIOCARTA IL2RB PATHWAY
REACTOME CELLEXTRACELLULAR MATRIX INTERACTIONS
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
PUJANA BREAST CANCER WITH BRCA1 MUTATED UP
KIM WT1 TARGETS 8HR UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
ELVIDGE HIF1A TARGETS DN
MORI SMALL PRE BII LYMPHOCYTE UP
LI CISPLATIN RESISTANCE DN
THEILGAARD NEUTROPHIL AT SKIN WOUND DN
RODRIGUES NTN1 AND DCC TARGETS
KOYAMA SEMA3B TARGETS UP
MUELLER COMMON TARGETS OF AML FUSIONS DN
THUM MIR21 TARGETS HEART DISEASE UP
CHEN LVAD SUPPORT OF FAILING HEART UP
HELLER HDAC TARGETS SILENCED BY METHYLATION DN
MCBRYAN PUBERTAL BREAST 4 5WK UP
NETPATH IL 1 PATHWAY
RODRIGUES THYROID CARCINOMA ANAPLASTIC UP
YAGI AML FAB MARKERS
REACTOME GLUCOSE REGULATION OF INSULIN SECRETION
NETPATH TGFBETA RECEPTOR PATHWAY UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
MORI EMU MYC LYMPHOMA BY ONSET TIME DN
ASTIER INTEGRIN SIGNALING
NCI IL6 7PATHWAY
BROWNE INTERFERON RESPONSIVE GENES
PASQUALUCCI LYMPHOMA BY GC STAGE DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
BOYAULT LIVER CANCER SUBCLASS G23 UP
AKL HTLV1 INFECTION DN
DAZARD UV RESPONSE CLUSTER G3
OSADA ASCL1 TARGETS DN
GALLUZZI PERMEABILIZE MITOCHONDRIA
PYEON HPV POSITIVE TUMORS UP
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
CHUNG BLISTER CYTOTOXICITY DN
REACTOME PROSTANOID HORMONES
KANG CISPLATIN RESISTANCE UP
ZHOU INFLAMMATORY RESPONSE LIVE UP
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS RED UP
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
LU AGING BRAIN DN
SAKAI CHRONIC HEPATITIS VS LIVER CANCER UP
GINESTIER BREAST CANCER 20Q13 AMPLIFICATION DN
NEWMAN ERCC6 TARGETS UP
KEGG OXIDATIVE PHOSPHORYLATION
FOSTER INFLAMMATORY RESPONSE LPS DN
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
BLUM RESPONSE TO SALIRASIB DN
CLAUS PGR POSITIVE MENINGIOMA DN
TING SILENCED BY DICER
VETTER TARGETS OF PRKCA AND ETS1 DN
SUNG METASTASIS STROMA DN
GESERICK TERT TARGETS DN
AMIT SERUM RESPONSE 120 MCF10A
BIOCARTA SRCRPTP PATHWAY
APPEL IMATINIB RESPONSE
REACTOME REGULATION OF INSULIN SECRETION
BOYLAN MULTIPLE MYELOMA D CLUSTER DN
NCI IL1PATHWAY
SESTO RESPONSE TO UV C8
BIOCARTA 41BB PATHWAY
TURASHVILI BREAST LOBULAR CARCINOMA VS LOBULAR NORMAL DN
GEISS RESPONSE TO DSRNA UP
SA B CELL RECEPTOR COMPLEXES
DELLA RESPONSE TO TSA AND BUTYRATE
GENTILE UV HIGH DOSE DN
KEGG ALZHEIMERS DISEASE
GRUETZMANN PANCREATIC CANCER UP
OKUMURA INFLAMMATORY RESPONSE LPS
VALK AML WITH CEBPA
NCI ARF6 PATHWAY
KRIGE AMINO ACID DEPRIVATION
BIOCARTA CASPASE PATHWAY
AMIT EGF RESPONSE 60 MCF10A
BENPORATH PROLIFERATION
CHEN HOXA5 TARGETS 6HR UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
NCI TCRCALCIUMPATHWAY
NAKAYAMA SOFT TISSUE TUMORS PCA2 UP
RODWELL AGING KIDNEY NO BLOOD UP
LEONARD HYPOXIA
BIOCARTA FAS PATHWAY
GOZGIT ESR1 TARGETS UP
FLECHNER PBL KIDNEY TRANSPLANT REJECTED VS OK DN
NCI NFKAPPABATYPICALPATHWAY
WU CELL MIGRATION
BROWNE HCMV INFECTION 2HR DN
ONDER CDH1 SIGNALING VIA CTNNB1
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
ZHONG RESPONSE TO AZACITIDINE AND TSA UP
AMIT EGF RESPONSE 480 MCF10A
DORN ADENOVIRUS INFECTION 12HR DN
NCI ERBB1 RECEPTOR PROXIMAL PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP
SANA TNF SIGNALING DN
SWEET LUNG CANCER KRAS DN
XU RESPONSE TO TRETINOIN AND NSC682994 UP
LAIHO COLORECTAL CANCER SERRATED UP
BHATI G2M ARREST BY 2METHOXYESTRADIOL UP
REACTOME CYCLIN A1 ASSOCIATED EVENTS DURING G2 M TRANSITION
ROY WOUND BLOOD VESSEL UP
REACTOME TOLL LIKE RECEPTOR 3 CASCADE
LIU SOX4 TARGETS UP
WATANABE COLON CANCER MSI VS MSS UP
GOLDRATH ANTIGEN RESPONSE
KEGG EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION
BILD HRAS ONCOGENIC SIGNATURE
ZHAN V2 LATE DIFFERENTIATION GENES
FLECHNER PBL KIDNEY TRANSPLANT OK VS DONOR DN
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
RIGGI EWING SARCOMA PROGENITOR DN
DER IFN ALPHA RESPONSE UP
NETPATH KIT RECEPTOR PATHWAY
CROONQUIST IL6 DEPRIVATION UP
BERENJENO TRANSFORMED BY RHOA FOREVER DN
AMIT EGF RESPONSE 60 HELA
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
DAZARD UV RESPONSE CLUSTER G2
AMUNDSON DNA DAMAGE RESPONSE TP53
AMUNDSON RESPONSE TO ARSENITE
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
SANA TNF SIGNALING UP
THUM SYSTOLIC HEART FAILURE UP
SENESE HDAC1 AND HDAC2 TARGETS UP
LIAO METASTASIS
MANALO HYPOXIA UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
CASTELLANO NRAS TARGETS UP
HOFFMANN LARGE TO SMALL PRE BII LYMPHOCYTE DN
NCI PI3KCIPATHWAY
VECCHI GASTRIC CANCER ADVANCED VS EARLY UP
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
BIOCARTA KERATINOCYTE PATHWAY
CORUM UBIQUITIN LIGASE COMPLEX TRAF6 TAB2 MALT1 UEV1A BCL10
NCI NFKAPPABCANONICALPATHWAY
FARMER BREAST CANCER CLUSTER 2
HELLER HDAC TARGETS DN
NETPATH IL 2 PATHWAY UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
CROONQUIST NRAS VS STROMAL STIMULATION DN
BOHN PRIMARY IMMUNODEFICIENCY SYNDROM DN
NCI PDGFRBPATHWAY
NETPATH IL 4 PATHWAY
GAUSSMANN MLL AF4 FUSION TARGETS F DN
NUNODA RESPONSE TO DASATINIB IMATINIB DN
IVANOVA HEMATOPOIESIS MATURE CELL
DAZARD RESPONSE TO UV SCC DN
NCI BCR 5PATHWAY
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
TURJANSKI MAPK7 TARGETS
PUJANA BRCA2 PCC NETWORK
BIOCARTA IL6 PATHWAY
LINDGREN BLADDER CANCER CLUSTER 2B
CHUANG OXIDATIVE STRESS RESPONSE UP
DOANE RESPONSE TO ANDROGEN DN
VARELA ZMPSTE24 TARGETS UP
KEGG LYSOSOME
NCI TNFPATHWAY
BIOCARTA MAPK PATHWAY
CHEN HOXA5 TARGETS 6HR DN
BRUECKNER TARGETS OF MIRLET7A3 DN
RASHI RESPONSE TO IONIZING RADIATION 2
CORUM CDC2-PCNA-CCNB1-GADD45B COMPLEX
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT DN
LINDSTEDT DENDRITIC CELL MATURATION D
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
AMIT EGF RESPONSE 40 HELA
CHAUHAN RESPONSE TO METHOXYESTRADIOL DN
MITSIADES RESPONSE TO APLIDIN UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
ZHU CMV 24 HR DN
MARTORIATI MDM4 TARGETS FETAL LIVER UP
HINATA NFKB TARGETS KERATINOCYTE UP
RUTELLA RESPONSE TO CSF2RB AND IL4 UP
CORUM CD20-LCK-LYN-FYN-P75/80 COMPLEX RAJI HUMAN B CELL LINE
MARKEY RB1 ACUTE LOF UP
REN ALVEOLAR RHABDOMYOSARCOMA DN
HUANG FOXA2 TARGETS UP
NCI MYC REPRESSPATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D DN
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN
KORKOLA TERATOMA
BIOCARTA CD40 PATHWAY
SHIPP DLBCL VS FOLLICULAR LYMPHOMA UP
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 DN
TOMIDA METASTASIS DN
BIOCARTA RANKL PATHWAY
DANG REGULATED BY MYC DN
KYNG DNA DAMAGE DN
REACTOME ELECTRON TRANSPORT CHAIN
ZHANG BREAST CANCER PROGENITORS DN
PODAR RESPONSE TO ADAPHOSTIN UP
HOSHIDA LIVER CANCER SUBCLASS S1
KYNG DNA DAMAGE UP
LEE LIVER CANCER E2F1 UP
WANG SMARCE1 TARGETS DN
KERLEY RESPONSE TO CISPLATIN UP
NETPATH TGFBETA RECEPTOR PATHWAY DOWN
NING CHRONIC OBSTRUCTIVE PULMONARY DISEASE DN
VANTVEER BREAST CANCER ESR1 DN
BROCKE APOPTOSIS REVERSED BY IL6
NETPATH TGFBETA RECEPTOR PATHWAY
CHANDRAN METASTASIS TOP50 DN
MA PITUITARY FETAL VS ADULT UP
GERY CEBP TARGETS
NCI P53DOWNSTREAMPATHWAY
ZHANG PROLIFERATING VS QUIESCENT
HUMMEL BURKITTS LYMPHOMA DN
GENTILE UV LOW DOSE UP
LEE EARLY T LYMPHOCYTE DN
HUANG DASATINIB RESISTANCE UP
HINATA NFKB TARGETS FIBROBLAST UP
PAPASPYRIDONOS UNSTABLE ATEROSCLEROTIC PLAQUE UP
MOOTHA HUMAN MITODB 6 2002
CROONQUIST STROMAL STIMULATION UP
BERENJENO TRANSFORMED BY RHOA REVERSIBLY DN
CHIARADONNA NEOPLASTIC TRANSFORMATION CDC25 UP
NCI MAPKTRKPATHWAY
ZHANG RESPONSE TO CANTHARIDIN UP
KINSEY TARGETS OF EWSR1 FLII FUSION DN
KANG IMMORTALIZED BY TERT UP
LINDGREN BLADDER CANCER CLUSTER 3 DN
KHETCHOUMIAN TRIM24 TARGETS UP
BIOCARTA CDMAC PATHWAY
OUYANG PROSTATE CANCER PROGRESSION UP
HORIUCHI WTAP TARGETS UP
ONKEN UVEAL MELANOMA UP
NCI CMYB PATHWAY
WOO LIVER CANCER RECURRENCE UP
SASAKI ADULT T CELL LEUKEMIA
CASORELLI APL SECONDARY VS DE NOVO UP
NETPATH B CELL RECEPTOR PATHWAY
DAVICIONI TARGETS OF PAX FOXO1 FUSIONS UP
HENDRICKS SMARCA4 TARGETS UP
NCI KITPATHWAY
CLASPER LYMPHATIC VESSELS DURING METASTASIS DN
DER IFN BETA RESPONSE UP
MORI PRE BI LYMPHOCYTE DN
FOURNIER ACINAR DEVELOPMENT LATE DN
GARY CD5 TARGETS UP
NUNODA RESPONSE TO DASATINIB IMATINIB UP
GILDEA METASTASIS
NCI LEUKOTRIENE SYNTHESIS
HAHTOLA SEZARY SYNDROM UP
BASSO CD40 SIGNALING UP
CHANG POU5F1 TARGETS UP
TIAN TNF SIGNALING NOT VIA NFKB
BIOCARTA FCER1 PATHWAY
KORKOLA EMBRYONAL CARCINOMA UP
NAGASHIMA NRG1 SIGNALING UP
RAGHAVACHARI PLATELET SPECIFIC GENES
ZERBINI RESPONSE TO SULINDAC UP
WANG ESOPHAGUS CANCER VS NORMAL UP
SASSON RESPONSE TO FORSKOLIN DN
CORUM SMAD7-SMURF1 COMPLEX
CHEMNITZ RESPONSE TO PROSTAGLANDIN E2 UP
PUJANA XPRSS INT NETWORK
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
GEORGES CELL CYCLE MIR192 TARGETS
NUTT GBM VS AO GLIOMA UP
BIOCARTA PAR1 PATHWAY
ELVIDGE HIF1A AND HIF2A TARGETS DN
KYNG ENVIRONMENTAL STRESS RESPONSE NOT BY 4NQO IN OLD
SESTO RESPONSE TO UV C7
CHEN HOXA5 TARGETS 9HR UP
KANNAN TP53 TARGETS UP
NETPATH IL 5 PATHWAY UP
RORIE TARGETS OF EWSR1 FLI1 FUSION UP
SEKI INFLAMMATORY RESPONSE LPS UP
NETPATH EGFR1 PATHWAY UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
PARK TRETINOIN RESPONSE AND PML RARA FUSION
ENGELMANN CANCER PROGENITORS UP
LEE RECENT THYMIC EMIGRANT
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP
REACTOME P38MAPK EVENTS
FONTAINE FOLLICULAR THYROID ADENOMA DN
LEE DIFFERENTIATING T LYMPHOCYTE
SENESE HDAC1 TARGETS UP
LIU TARGETS OF VMYB VS CMYB DN
INGA TP53 TARGETS
KIM WT1 TARGETS UP
REACTOME P75NTR SIGNALS VIA NFKB
HOLLMAN APOPTOSIS VIA CD40 UP
CROONQUIST NRAS SIGNALING UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
BOYLAN MULTIPLE MYELOMA PCA3 DN
IIZUKA RECURRENT LIVER CANCER
NETPATH WNT PATHWAY UP
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
BERENJENO ROCK SIGNALING NOT VIA RHOA DN
BIOCARTA ARENRF2 PATHWAY
NCI XANTHINE FORMATION
RUTELLA RESPONSE TO HGF UP
CORUM TNFRSF11A-TRAF6-SRC COMPLEX
HOSHIDA LIVER CANCER LATE RECURRENCE UP
PRAMOONJAGO SOX4 TARGETS UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
RUGO STRESS RESPONSE SUBSET G
ZHAN MULTIPLE MYELOMA CD1 AND CD2 UP
ROSS LEUKEMIA WITH MLL FUSIONS
MARTORIATI MDM4 TARGETS NEUROEPITHELIUM UP
NCI PLK1 PATHWAY
SWEET LUNG CANCER KRAS UP
REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING
TENEDINI MEGAKARYOCYTE MARKERS
CONRAD STEM CELL
LINDSTEDT DENDRITIC CELL MATURATION A
RUGO UV RESPONSE
WONG MITOCHONDRIA GENE MODULE
REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS
XU RESPONSE TO TRETINOIN UP
BASAKI YBX1 TARGETS DN
ELVIDGE HYPOXIA UP
KYNG DNA DAMAGE BY 4NQO OR UV
NETPATH T CELL RECEPTOR PATHWAY DOWN
RADMACHER AML PROGNOSIS
WU HBX TARGETS 3 UP
NUYTTEN NIPP1 TARGETS UP
FRIDMAN IMMORTALIZATION DN
ST TYPE I INTERFERON PATHWAY
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
HOOI ST7 TARGETS DN
XU HGF TARGETS INDUCED BY AKT1 48HR UP
WILLIAMS ESR2 TARGETS DN
TSAI RESPONSE TO IONIZING RADIATION
DELYS THYROID CANCER UP
KRISHNAN FURIN TARGETS UP
DIRMEIER LMP1 RESPONSE EARLY
ST GRANULE CELL SURVIVAL PATHWAY
AMIT SERUM RESPONSE 240 MCF10A
SEMENZA HIF1 TARGETS
ZHAN V1 LATE DIFFERENTIATION GENES UP
BIOCARTA ETS PATHWAY
KEGG COLORECTAL CANCER
ONDER CDH1 TARGETS 3 DN
TARTE PLASMA CELL VS B LYMPHOCYTE DN
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN 2FC DN
HELLEBREKERS SILENCED DURING TUMOR ANGIOGENESIS
GU PDEF TARGETS UP
GENTILE RESPONSE CLUSTER D3
WINTER HYPOXIA METAGENE
NETPATH TNF ALPHA PATHWAY
GAZDA DIAMOND BLACKFAN ANEMIA ERYTHROID UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
REACTOME INTEGRATION OF ENERGY METABOLISM
TAVOR CEBPA TARGETS UP
LU TUMOR VASCULATURE UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA UP
NETPATH TNF ALPHA PATHWAY UP
KEGG T CELL RECEPTOR SIGNALING PATHWAY
BROWNE HCMV INFECTION 2HR UP
BILBAN B CLL LPL UP
SESTO RESPONSE TO UV C3
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
ZHAN MULTIPLE MYELOMA DN
NETPATH IL 2 PATHWAY
BIOCARTA P38MAPK PATHWAY
SENESE HDAC2 TARGETS UP
HADDAD B LYMPHOCYTE PROGENITOR
ROZANOV MMP14 TARGETS UP
VECCHI GASTRIC CANCER EARLY UP
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
AMIT DELAYED EARLY GENES
RUGO STRESS RESPONSE SUBSET H
RHEIN ALL GLUCOCORTICOID THERAPY UP
NOJIMA SFRP2 TARGETS UP
KYNG DNA DAMAGE BY GAMMA AND UV RADIATION
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
FLECHNER BIOPSY KIDNEY TRANSPLANT REJECTED VS OK DN
NCI EPHRINBREVPATHWAY
ZHAN MULTIPLE MYELOMA HP DN
LEE LIVER CANCER DENA UP
HALMOS CEBPA TARGETS UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 9
ENK UV RESPONSE EPIDERMIS UP
NETPATH EGFR1 PATHWAY
ST INTERFERON GAMMA PATHWAY
REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE
MAHADEVAN RESPONSE TO MP470 DN
HARRIS HYPOXIA
HUPER BREAST BASAL VS LUMINAL DN
KARAKAS TGFB1 SIGNALING
TURASHVILI BREAST DUCTAL CARCINOMA VS DUCTAL NORMAL UP
KAN RESPONSE TO ARSENIC TRIOXIDE
SOUCEK MYC TARGETS
ENGELMANN CANCER PROGENITORS DN
SCIAN INVERSED TARGETS OF TP53 AND TP73 DN
BILBAN B CLL LPL DN
KEGG B CELL RECEPTOR SIGNALING PATHWAY
IZADPANAH STEM CELL ADIPOSE VS BONE UP
TOMLINS METASTASIS DN
GENTILE UV LOW DOSE DN
ZHAN MULTIPLE MYELOMA LB DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC UP
RUTELLA RESPONSE TO HGF DN
LEE LIVER CANCER ACOX1 UP
KEGG HUNTINGTONS DISEASE
LEE LIVER CANCER SURVIVAL DN
AMIT SERUM RESPONSE 40 MCF10A
GUENTHER GROWTH SPHERICAL VS ADHERENT DN
HELLER HDAC TARGETS SILENCED BY METHYLATION UP
HOOI ST7 TARGETS UP
GAUSSMANN MLL AF4 FUSION TARGETS F UP
HELLER SILENCED BY METHYLATION DN
BIERIE INFLAMMATORY RESPONSE TGFB1
SCHUETZ BREAST CANCER DUCTAL INVASIVE UP
ONDER CDH1 TARGETS 2 DN
UDAYAKUMAR MED1 TARGETS DN
SENESE HDAC3 TARGETS UP
KRIGE RESPONSE TO TOSEDOSTAT 6HR UP
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN
XU HGF SIGNALING NOT VIA AKT1 6HR
JISON SICKLE CELL DISEASE UP
CORUM 55S RIBOSOME MITOCHONDRIAL
KEGG CELL CYCLE
XU HGF SIGNALING NOT VIA AKT1 48HR UP
DASU IL6 SIGNALING UP
BROWNE HCMV INFECTION 8HR DN
HUPER BREAST BASAL VS LUMINAL UP
ZUCCHI METASTASIS DN
DEURIG T CELL PROLYMPHOCYTIC LEUKEMIA DN
OKAMOTO LIVER CANCER MULTICENTRIC OCCURRENCE UP
FERRANDO T ALL WITH MLL ENL FUSION UP
LINDGREN BLADDER CANCER CLUSTER 1 DN
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
ehrlichia chaffeensis wakullastreptococcus pneumoniae g54GeneSet Name
0.00000 0.03328CORUM_RESPIRATORY_CHAIN_COMPLEX_I_HOLOENZYME_MITOCHONDRIAL
0.00000 0.05316MOOTHA_VOXPHOS
0.00022 0.02186NETPATH_IL_1_PATHWAY_UP
0.00011 0.04087NETPATH_IL_2_PATHWAY_DOWN
0.00000 0.01842NETPATH_IL_6_PATHWAY_UP
0.00196 0.03036NCI_ATF2_PATHWAY
0.00075 0.04700NETPATH_IL_5_PATHWAY
0.09159 0.16975NCI_COLLAGEN_ADHESION_VIA_ALPHA_2_BETA_1_GLYCOPROTEIN
0.14891 0.09311ITO_PTTG1_TARGETS_UP
0.14169 0.13876CORUM_UBIQUITIN_E3_LIGASE_NFKBIA_FBXW11_CUL1_SKP1A
0.00447 0.08911MAHAJAN_RESPONSE_TO_IL1A_UP
0.04046 0.00875WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.18544 0.09864REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS
0.00000 0.00817LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00096 0.10801HUANG_FOXA2_TARGETS_DN
0.13791 0.07896GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP
0.00005 0.05358COATES_MACROPHAGE_M1_VS_M2_UP
0.00004 0.11486NETPATH_IL_7_PATHWAY_UP
0.00056 0.17226MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
0.00533 0.00621WANG_SMARCE1_TARGETS_UP
0.00104 0.14370NAKAYAMA_FRA2_TARGETS
0.00032 0.02288JEON_SMAD6_TARGETS_UP
0.06953 0.01665LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
0.14172 0.11236HASINA_NOL7_TARGETS_UP
0.00039 0.12095KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.17888 0.05238SCIBETTA_KDM5B_TARGETS_UP
0.00605 0.16647ALCALA_APOPTOSIS
0.00184 0.12091BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.11672 0.02436KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.01765 0.10049NCI_HIF1_TFPATHWAY
0.00777 0.00641COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.04386 0.00558GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.16833 0.11132MARTINEZ_RB1_AND_TP53_TARGETS_UP
0.05709 0.04828HAN_SATB1_TARGETS_DN
0.12943 0.04431MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
0.00183 0.06013CERVERA_SDHB_TARGETS_1_UP
0.14236 0.05556NCI_REG_GR_PATHWAY
0.10957 0.18339CORUM_PRB2/P130-MULTIMOLECULAR_COMPLEX_RB2_E2F5_HDAC1_SUV39H1_P300
0.00000 0.08507SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
0.16910 0.15437DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.00037 0.01466AMIT_EGF_RESPONSE_120_HELA
0.18155 0.15199REACTOME_APOPTOSIS
0.00161 0.00715FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.13220 0.10260KYNG_DNA_DAMAGE_BY_UV
0.00261 0.00696GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.04541 0.19144BIOCARTA_TCR_PATHWAY
0.00000 0.17361HELLER_SILENCED_BY_METHYLATION_UP
0.10938 0.04965WOOD_EBV_EBNA1_TARGETS_DN
0.00442 0.01015LAU_APOPTOSIS_CDKN2A_UP
0.10943 0.03000GOZGIT_ESR1_TARGETS_DN
0.07216 0.13908BIOCARTA_CARDIACEGF_PATHWAY
0.02136 0.07814NCI_P38ALPHABETAPATHWAY
0.05070 0.05440BROWNE_HCMV_INFECTION_14HR_UP
0.05689 0.10101SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.00506 0.09492BERENJENO_TRANSFORMED_BY_RHOA_UP
0.16009 0.08343CORUM_REL-MAP3K8-RELA-TNIP2-PAPOLA_COMPLEX
0.00000 0.12533VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.12283 0.02072SPIRA_SMOKERS_LUNG_CANCER_UP
0.00254 0.10551ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.00000 0.16057TIAN_TNF_SIGNALING_VIA_NFKB
0.04468 0.03610CHASSOT_SKIN_WOUND
0.02131 0.00439CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.00860 0.08578KEGG_APOPTOSIS
0.18309 0.03853DODD_NASOPHARYNGEAL_CARCINOMA_DN
0.00050 0.06179CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.00068 0.04921HOSHIDA_LIVER_CANCER_SURVIVAL_UP
0.00000 0.00034CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00006 0.00810MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.00422 0.05057CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
0.03547 0.05447ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
0.08807 0.00177DAZARD_RESPONSE_TO_UV_NHEK_DN
0.00835 0.01832GEORGANTAS_HSC_MARKERS
0.02416 0.14421RHODES_UNDIFFERENTIATED_CANCER
0.05475 0.10890BROWNE_HCMV_INFECTION_12HR_UP
0.09644 0.07883TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
0.14764 0.04460ONDER_CDH1_TARGETS_1_UP
0.06993 0.07896BIOCARTA_BCR_PATHWAY
0.00016 0.06977BOYLAN_MULTIPLE_MYELOMA_D_DN
0.14661 0.08223IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
0.09106 0.06582CORUM_ITGA2B-ITGB3-FN1-TGM2_COMPLEX
0.00165 0.00388KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
0.09657 0.07564KEGG_SMALL_CELL_LUNG_CANCER
0.00003 0.07629VERNELL_RETINOBLASTOMA_PATHWAY_UP
0.00000 0.03089RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.00037 0.15862MULLIGHAN_MLL_SIGNATURE_2_UP
0.00022 0.02167CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.08711 0.17451NCI_LYSOPHOSPHOLIPID_PATHWAY
0.14927 0.16976SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.02072 0.07134GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.00056 0.01803DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.04314 0.03948NETPATH_IL_6_PATHWAY
0.00539 0.06964DIRMEIER_LMP1_RESPONSE_LATE_UP
0.01408 0.11520GALI_TP53_TARGETS_APOPTOTIC_UP
0.00184 0.04591AMIT_EGF_RESPONSE_20_HELA
0.00236 0.06096NETPATH_IL_3_PATHWAY
0.14706 0.04158BIOCARTA_NTHI_PATHWAY
0.00004 0.16651MARZEC_IL2_SIGNALING_UP
0.00044 0.14802TANG_SENESCENCE_TP53_TARGETS_DN
0.00486 0.00638LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.04439 0.00387ENK_UV_RESPONSE_EPIDERMIS_DN
0.00628 0.03706FRIDMAN_SENESCENCE_UP
0.08461 0.02045CROMER_TUMORIGENESIS_UP
0.12614 0.08094BLALOCK_ALZHEIMERS_DISEASE_UP
0.05159 0.11292KEGG_PANCREATIC_CANCER
0.00156 0.01205FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.15357 0.04805DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.00056 0.09057AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
0.00035 0.06984AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.00000 0.15101SANA_RESPONSE_TO_IFNG_UP
0.02027 0.10985BENPORATH_CYCLING_GENES
0.04151 0.18050CASTELLANO_NRAS_TARGETS_DN
0.00733 0.01310CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
0.14235 0.00052LUI_THYROID_CANCER_CLUSTER_1
0.05492 0.08884NCI_ENDOTHELINPATHWAY
0.11208 0.07559WU_HBX_TARGETS_1_UP
0.00000 0.03928KEGG_PARKINSONS_DISEASE
0.13271 0.00812WANG_BARRETTS_ESOPHAGUS_DN
0.14402 0.02049IGARASHI_ATF4_TARGETS_DN
0.18411 0.05644BENPORATH_ES_CORE_NINE_CORRELATED
0.00635 0.00034HOEBEKE_LYMPHOID_STEM_CELL_UP
0.00000 0.12552MOOTHA_MITOCHONDRIA
0.08522 0.19001DOANE_BREAST_CANCER_ESR1_DN
0.00001 0.13871MULLIGHAN_MLL_SIGNATURE_1_UP
0.05272 0.02474WANG_METHYLATED_IN_BREAST_CANCER
0.08701 0.02451HOLLMAN_APOPTOSIS_VIA_CD40_DN
0.00067 0.15988REACTOME_TOLL_RECEPTOR_CASCADES
0.00022 0.19023ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.08705 0.03113BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.15849 0.19453KENNY_CTNNB1_TARGETS_UP
0.13248 0.07758ONDER_CDH1_TARGETS_1_DN
0.00000 0.03747CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
0.06001 0.09084BIOCARTA_IL7_PATHWAY
0.10210 0.02286NCI_SMAD2_3NUCLEARPATHWAY
0.11084 0.00761LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.01140 0.03886OSMAN_BLADDER_CANCER_UP
0.00131 0.00018ELVIDGE_HYPOXIA_BY_DMOG_UP
0.01506 0.02707BROWNE_HCMV_INFECTION_48HR_UP
0.02482 0.02681VANTVEER_BREAST_CANCER_METASTASIS_DN
0.01445 0.01752BIOCARTA_IL2RB_PATHWAY
0.01636 0.09869REACTOME_CELLEXTRACELLULAR_MATRIX_INTERACTIONS
0.00265 0.01851OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00000 0.16445PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
0.07001 0.01014KIM_WT1_TARGETS_8HR_UP
0.00107 0.00267PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.02625 0.00071ELVIDGE_HIF1A_TARGETS_DN
0.08863 0.05390MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.06248 0.04065LI_CISPLATIN_RESISTANCE_DN
0.00022 0.13865THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
0.16874 0.00522RODRIGUES_NTN1_AND_DCC_TARGETS
0.01498 0.12371KOYAMA_SEMA3B_TARGETS_UP
0.03586 0.13820MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.01101 0.08374THUM_MIR21_TARGETS_HEART_DISEASE_UP
0.01382 0.01145CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.01520 0.09151HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
0.00085 0.03294MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.10950 0.03624NETPATH_IL_1_PATHWAY
0.10588 0.02036RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
0.01139 0.07751YAGI_AML_FAB_MARKERS
0.00000 0.07640REACTOME_GLUCOSE_REGULATION_OF_INSULIN_SECRETION
0.01445 0.03675NETPATH_TGFBETA_RECEPTOR_PATHWAY_UP
0.02739 0.03309YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.01382 0.09386MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.14340 0.19173ASTIER_INTEGRIN_SIGNALING
0.00000 0.10802NCI_IL6_7PATHWAY
0.00000 0.11107BROWNE_INTERFERON_RESPONSIVE_GENES
0.00001 0.11158PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
0.08132 0.14828TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.09058 0.08516BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
0.12530 0.12713AKL_HTLV1_INFECTION_DN
0.03040 0.03860DAZARD_UV_RESPONSE_CLUSTER_G3
0.00002 0.03295OSADA_ASCL1_TARGETS_DN
0.07214 0.14118GALLUZZI_PERMEABILIZE_MITOCHONDRIA
0.09428 0.18329PYEON_HPV_POSITIVE_TUMORS_UP
0.00144 0.00276NUYTTEN_EZH2_TARGETS_UP
0.00000 0.05455DUTTA_APOPTOSIS_VIA_NFKB
0.00241 0.06094CHUNG_BLISTER_CYTOTOXICITY_DN
0.01391 0.05827REACTOME_PROSTANOID_HORMONES
0.15386 0.08920KANG_CISPLATIN_RESISTANCE_UP
0.00039 0.11282ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00006 0.01828RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.00872 0.09080GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
0.00276 0.13119NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.18010 0.00736LU_AGING_BRAIN_DN
0.18191 0.05988SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
0.07781 0.03776GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
0.00209 0.04821NEWMAN_ERCC6_TARGETS_UP
0.00000 0.07632KEGG_OXIDATIVE_PHOSPHORYLATION
0.00000 0.01680FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.04099 0.02405SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.12031 0.18659BLUM_RESPONSE_TO_SALIRASIB_DN
0.00681 0.00575CLAUS_PGR_POSITIVE_MENINGIOMA_DN
0.14043 0.07877TING_SILENCED_BY_DICER
0.08455 0.17444VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN
0.07111 0.00826SUNG_METASTASIS_STROMA_DN
0.00032 0.00310GESERICK_TERT_TARGETS_DN
0.00009 0.00320AMIT_SERUM_RESPONSE_120_MCF10A
0.01971 0.18446BIOCARTA_SRCRPTP_PATHWAY
0.00619 0.04083APPEL_IMATINIB_RESPONSE
0.00000 0.10468REACTOME_REGULATION_OF_INSULIN_SECRETION
0.05125 0.09097BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
0.06247 0.18632NCI_IL1PATHWAY
0.11826 0.00644SESTO_RESPONSE_TO_UV_C8
0.15758 0.19974BIOCARTA_41BB_PATHWAY
0.03476 0.12555TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.00022 0.03258GEISS_RESPONSE_TO_DSRNA_UP
0.08463 0.08216SA_B_CELL_RECEPTOR_COMPLEXES
0.07356 0.16946DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
0.12305 0.00382GENTILE_UV_HIGH_DOSE_DN
0.00000 0.07325KEGG_ALZHEIMERS_DISEASE
0.00009 0.00920GRUETZMANN_PANCREATIC_CANCER_UP
0.15053 0.04102OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.05146 0.09852VALK_AML_WITH_CEBPA
0.19177 0.19225NCI_ARF6_PATHWAY
0.04509 0.04467KRIGE_AMINO_ACID_DEPRIVATION
0.00291 0.07295BIOCARTA_CASPASE_PATHWAY
0.00070 0.00090AMIT_EGF_RESPONSE_60_MCF10A
0.00594 0.04449BENPORATH_PROLIFERATION
0.01388 0.01846CHEN_HOXA5_TARGETS_6HR_UP
0.00000 0.01189SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.05207 0.15695NCI_TCRCALCIUMPATHWAY
0.01875 0.07352NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
0.00025 0.16924RODWELL_AGING_KIDNEY_NO_BLOOD_UP
0.00008 0.00548LEONARD_HYPOXIA
0.09240 0.19709BIOCARTA_FAS_PATHWAY
0.05224 0.07131GOZGIT_ESR1_TARGETS_UP
0.12281 0.03334FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
0.03445 0.11228NCI_NFKAPPABATYPICALPATHWAY
0.00166 0.00050WU_CELL_MIGRATION
0.00158 0.09008BROWNE_HCMV_INFECTION_2HR_DN
0.02499 0.01436ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.02715 0.04993GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.00376 0.09090ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.19773 0.10254AMIT_EGF_RESPONSE_480_MCF10A
0.19163 0.10988DORN_ADENOVIRUS_INFECTION_12HR_DN
0.11434 0.00612NCI_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
0.00000 0.08161TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.00000 0.12500FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.02669 0.02323KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.00156 0.04079CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.14050 0.10419SANA_TNF_SIGNALING_DN
0.03050 0.16976SWEET_LUNG_CANCER_KRAS_DN
0.00274 0.13879XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
0.10077 0.00722LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.14048 0.12316BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
0.09227 0.18037REACTOME_CYCLIN_A1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION
0.00104 0.04746ROY_WOUND_BLOOD_VESSEL_UP
0.06249 0.04826REACTOME_TOLL_LIKE_RECEPTOR_3_CASCADE
0.16808 0.02029LIU_SOX4_TARGETS_UP
0.10071 0.04220WATANABE_COLON_CANCER_MSI_VS_MSS_UP
0.00000 0.18885GOLDRATH_ANTIGEN_RESPONSE
0.13799 0.07363KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.00024 0.00093BILD_HRAS_ONCOGENIC_SIGNATURE
0.16057 0.01305ZHAN_V2_LATE_DIFFERENTIATION_GENES
0.11113 0.11804FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.00000 0.01216LIANG_SILENCED_BY_METHYLATION_2
0.00307 0.03237DAUER_STAT3_TARGETS_UP
0.18462 0.06354RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.00122 0.11860DER_IFN_ALPHA_RESPONSE_UP
0.00592 0.10688NETPATH_KIT_RECEPTOR_PATHWAY
0.10011 0.07750CROONQUIST_IL6_DEPRIVATION_UP
0.00358 0.02282BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.00102 0.02905AMIT_EGF_RESPONSE_60_HELA
0.03269 0.09462ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.00111 0.03619DAZARD_UV_RESPONSE_CLUSTER_G2
0.02275 0.07960AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
0.17410 0.00551AMUNDSON_RESPONSE_TO_ARSENITE
0.00000 0.00231ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00000 0.15203SANA_TNF_SIGNALING_UP
0.00085 0.19736THUM_SYSTOLIC_HEART_FAILURE_UP
0.01080 0.15156SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00580 0.02426LIAO_METASTASIS
0.00557 0.00075MANALO_HYPOXIA_UP
0.00004 0.00067HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.00260 0.11522CASTELLANO_NRAS_TARGETS_UP
0.00103 0.14422HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
0.00007 0.15722NCI_PI3KCIPATHWAY
0.00340 0.01922VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.00336 0.00000UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.05653 0.06149BIOCARTA_KERATINOCYTE_PATHWAY
0.16092 0.19000CORUM_UBIQUITIN_LIGASE_COMPLEX_TRAF6_TAB2_MALT1_UEV1A_BCL10
0.02559 0.05639NCI_NFKAPPABCANONICALPATHWAY
0.02350 0.02097FARMER_BREAST_CANCER_CLUSTER_2
0.00974 0.17928HELLER_HDAC_TARGETS_DN
0.00006 0.16635NETPATH_IL_2_PATHWAY_UP
0.00009 0.03864GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00000 0.17834CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.00531 0.15770BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.03222 0.06985NCI_PDGFRBPATHWAY
0.00029 0.07835NETPATH_IL_4_PATHWAY
0.05601 0.15088GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN
0.02137 0.09293NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
0.00053 0.16945IVANOVA_HEMATOPOIESIS_MATURE_CELL
0.16326 0.00931DAZARD_RESPONSE_TO_UV_SCC_DN
0.00101 0.05244NCI_BCR_5PATHWAY
0.00547 0.03257GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.06383 0.11975TURJANSKI_MAPK7_TARGETS
0.08401 0.10181PUJANA_BRCA2_PCC_NETWORK
0.12285 0.06093BIOCARTA_IL6_PATHWAY
0.00000 0.08248LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.12450 0.12323CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.06245 0.04756DOANE_RESPONSE_TO_ANDROGEN_DN
0.00013 0.01900VARELA_ZMPSTE24_TARGETS_UP
0.18958 0.04429KEGG_LYSOSOME
0.06530 0.16078NCI_TNFPATHWAY
0.01697 0.04422BIOCARTA_MAPK_PATHWAY
0.10524 0.14087CHEN_HOXA5_TARGETS_6HR_DN
0.02134 0.00199BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.00001 0.00271RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.14476 0.19106CORUM_CDC2-PCNA-CCNB1-GADD45B_COMPLEX
0.02903 0.04813LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.00089 0.09379GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.00007 0.08206LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.01247 0.03272IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.00042 0.02615AMIT_EGF_RESPONSE_40_HELA
0.00223 0.04001CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.03497 0.00669MITSIADES_RESPONSE_TO_APLIDIN_UP
0.00174 0.09013THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.00001 0.13995TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.08019 0.19723ZHU_CMV_24_HR_DN
0.13788 0.07515MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.00001 0.00568HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.04484 0.00276RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
0.10384 0.11106CORUM_CD20-LCK-LYN-FYN-P75/80_COMPLEX_RAJI_HUMAN_B_CELL_LINE
0.00000 0.10730MARKEY_RB1_ACUTE_LOF_UP
0.00833 0.00269REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
0.08277 0.08226HUANG_FOXA2_TARGETS_UP
0.10943 0.17907NCI_MYC_REPRESSPATHWAY
0.00958 0.10702TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.00259 0.00390RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.15100 0.07871KORKOLA_TERATOMA
0.04824 0.09309BIOCARTA_CD40_PATHWAY
0.07201 0.16929SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
0.00031 0.00340RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.14755 0.04304TOMIDA_METASTASIS_DN
0.01515 0.11238BIOCARTA_RANKL_PATHWAY
0.00067 0.07999DANG_REGULATED_BY_MYC_DN
0.06238 0.03835KYNG_DNA_DAMAGE_DN
0.00000 0.02389REACTOME_ELECTRON_TRANSPORT_CHAIN
0.08703 0.14116ZHANG_BREAST_CANCER_PROGENITORS_DN
0.00028 0.00016PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00000 0.08375HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.00007 0.00926KYNG_DNA_DAMAGE_UP
0.00000 0.05639LEE_LIVER_CANCER_E2F1_UP
0.12698 0.03606WANG_SMARCE1_TARGETS_DN
0.00855 0.01965KERLEY_RESPONSE_TO_CISPLATIN_UP
0.00363 0.14788NETPATH_TGFBETA_RECEPTOR_PATHWAY_DOWN
0.12994 0.02013NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
0.00000 0.05316VANTVEER_BREAST_CANCER_ESR1_DN
0.00000 0.09635BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.14001 0.07165NETPATH_TGFBETA_RECEPTOR_PATHWAY
0.05607 0.16467CHANDRAN_METASTASIS_TOP50_DN
0.04086 0.17091MA_PITUITARY_FETAL_VS_ADULT_UP
0.00116 0.12493GERY_CEBP_TARGETS
0.03452 0.06541NCI_P53DOWNSTREAMPATHWAY
0.13478 0.14796ZHANG_PROLIFERATING_VS_QUIESCENT
0.00020 0.05491HUMMEL_BURKITTS_LYMPHOMA_DN
0.07239 0.16976GENTILE_UV_LOW_DOSE_UP
0.00005 0.06967LEE_EARLY_T_LYMPHOCYTE_DN
0.00093 0.00242HUANG_DASATINIB_RESISTANCE_UP
0.00151 0.02432HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.01784 0.10854PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP
0.00000 0.16922MOOTHA_HUMAN_MITODB_6_2002
0.00000 0.09861CROONQUIST_STROMAL_STIMULATION_UP
0.00483 0.11462BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.00163 0.14745CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.19620 0.05728NCI_MAPKTRKPATHWAY
0.03702 0.03275ZHANG_RESPONSE_TO_CANTHARIDIN_UP
0.08700 0.00396KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
0.00075 0.09051KANG_IMMORTALIZED_BY_TERT_UP
0.11586 0.00670LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
0.00000 0.02156KHETCHOUMIAN_TRIM24_TARGETS_UP
0.12269 0.16806BIOCARTA_CDMAC_PATHWAY
0.04529 0.04482OUYANG_PROSTATE_CANCER_PROGRESSION_UP
0.00059 0.00695HORIUCHI_WTAP_TARGETS_UP
0.10115 0.00069ONKEN_UVEAL_MELANOMA_UP
0.02081 0.01518NCI_CMYB_PATHWAY
0.00000 0.02446WOO_LIVER_CANCER_RECURRENCE_UP
0.16348 0.07440SASAKI_ADULT_T_CELL_LEUKEMIA
0.00518 0.00977CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP
0.00000 0.19416NETPATH_B_CELL_RECEPTOR_PATHWAY
0.14182 0.00923DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.08227 0.07872HENDRICKS_SMARCA4_TARGETS_UP
0.03891 0.02857NCI_KITPATHWAY
0.15497 0.03087CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN
0.00214 0.11870DER_IFN_BETA_RESPONSE_UP
0.00003 0.00687MORI_PRE_BI_LYMPHOCYTE_DN
0.12273 0.09809FOURNIER_ACINAR_DEVELOPMENT_LATE_DN
0.00330 0.02889GARY_CD5_TARGETS_UP
0.00005 0.11072NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
0.00141 0.10751GILDEA_METASTASIS
0.08799 0.15087NCI_LEUKOTRIENE_SYNTHESIS
0.00491 0.10582HAHTOLA_SEZARY_SYNDROM_UP
0.00000 0.03498BASSO_CD40_SIGNALING_UP
0.10270 0.16490CHANG_POU5F1_TARGETS_UP
0.00264 0.00388TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.01034 0.06296BIOCARTA_FCER1_PATHWAY
0.11198 0.04436KORKOLA_EMBRYONAL_CARCINOMA_UP
0.00000 0.00022NAGASHIMA_NRG1_SIGNALING_UP
0.00359 0.03851RAGHAVACHARI_PLATELET_SPECIFIC_GENES
0.11589 0.09092ZERBINI_RESPONSE_TO_SULINDAC_UP
0.00010 0.10110WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.04793 0.16936SASSON_RESPONSE_TO_FORSKOLIN_DN
0.12024 0.12212CORUM_SMAD7-SMURF1_COMPLEX
0.00337 0.12426CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
0.03422 0.19215PUJANA_XPRSS_INT_NETWORK
0.00466 0.02602ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.10214 0.00916GEORGES_CELL_CYCLE_MIR192_TARGETS
0.01090 0.17218NUTT_GBM_VS_AO_GLIOMA_UP
0.19756 0.19086BIOCARTA_PAR1_PATHWAY
0.00619 0.00054ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.09055 0.13874KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD
0.13265 0.02666SESTO_RESPONSE_TO_UV_C7
0.00291 0.00050CHEN_HOXA5_TARGETS_9HR_UP
0.14733 0.00648KANNAN_TP53_TARGETS_UP
0.00000 0.07746NETPATH_IL_5_PATHWAY_UP
0.01783 0.04298RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.00000 0.02093SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.03402 0.11210NETPATH_EGFR1_PATHWAY_UP
0.00003 0.11160GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.01806 0.01005CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.00001 0.15242PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.01538 0.00380ENGELMANN_CANCER_PROGENITORS_UP
0.03366 0.09093LEE_RECENT_THYMIC_EMIGRANT
0.06472 0.00031BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
0.03582 0.14414REACTOME_P38MAPK_EVENTS
0.00276 0.12710FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
0.00000 0.18334LEE_DIFFERENTIATING_T_LYMPHOCYTE
0.03717 0.05349SENESE_HDAC1_TARGETS_UP
0.00731 0.15815LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.00111 0.13640INGA_TP53_TARGETS
0.00017 0.00273KIM_WT1_TARGETS_UP
0.07392 0.13024REACTOME_P75NTR_SIGNALS_VIA_NFKB
0.09651 0.05031HOLLMAN_APOPTOSIS_VIA_CD40_UP
0.00000 0.17404CROONQUIST_NRAS_SIGNALING_UP
0.00000 0.13868HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.16010 0.06198BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
0.01342 0.08004IIZUKA_RECURRENT_LIVER_CANCER
0.17499 0.14364NETPATH_WNT_PATHWAY_UP
0.00001 0.10106BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.12832 0.10586BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.06878 0.02407BIOCARTA_ARENRF2_PATHWAY
0.03882 0.19352NCI_XANTHINE_FORMATION
0.00473 0.00850RUTELLA_RESPONSE_TO_HGF_UP
0.10670 0.19203CORUM_TNFRSF11A-TRAF6-SRC_COMPLEX
0.00000 0.06801HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.00099 0.00000PRAMOONJAGO_SOX4_TARGETS_UP
0.04364 0.07009YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.01402 0.06606RUGO_STRESS_RESPONSE_SUBSET_G
0.19445 0.04452ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
0.02348 0.02413ROSS_LEUKEMIA_WITH_MLL_FUSIONS
0.05648 0.07012MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
0.03974 0.04375NCI_PLK1_PATHWAY
0.04103 0.07052SWEET_LUNG_CANCER_KRAS_UP
0.02139 0.18685REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
0.00000 0.11247TENEDINI_MEGAKARYOCYTE_MARKERS
0.09001 0.05307CONRAD_STEM_CELL
0.00000 0.16372LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.13155 0.10355RUGO_UV_RESPONSE
0.00000 0.02432WONG_MITOCHONDRIA_GENE_MODULE
0.09109 0.03706REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS
0.05395 0.13874XU_RESPONSE_TO_TRETINOIN_UP
0.18263 0.00152BASAKI_YBX1_TARGETS_DN
0.00027 0.00034ELVIDGE_HYPOXIA_UP
0.01722 0.06577KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
0.00007 0.09456NETPATH_T_CELL_RECEPTOR_PATHWAY_DOWN
0.08004 0.13022RADMACHER_AML_PROGNOSIS
0.08662 0.15099WU_HBX_TARGETS_3_UP
0.16376 0.00315NUYTTEN_NIPP1_TARGETS_UP
0.05819 0.07577FRIDMAN_IMMORTALIZATION_DN
0.16006 0.04474ST_TYPE_I_INTERFERON_PATHWAY
0.00000 0.17463KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.14332 0.02851HOOI_ST7_TARGETS_DN
0.05349 0.18837XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.15069 0.02455WILLIAMS_ESR2_TARGETS_DN
0.00000 0.03105TSAI_RESPONSE_TO_IONIZING_RADIATION
0.00000 0.05377DELYS_THYROID_CANCER_UP
0.00348 0.11205KRISHNAN_FURIN_TARGETS_UP
0.00000 0.08905DIRMEIER_LMP1_RESPONSE_EARLY
0.14961 0.09235ST_GRANULE_CELL_SURVIVAL_PATHWAY
0.00269 0.01938AMIT_SERUM_RESPONSE_240_MCF10A
0.02278 0.17257SEMENZA_HIF1_TARGETS
0.00163 0.07579ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.02668 0.12208BIOCARTA_ETS_PATHWAY
0.13201 0.11149KEGG_COLORECTAL_CANCER
0.00507 0.03102ONDER_CDH1_TARGETS_3_DN
0.00000 0.07358TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
0.15100 0.02410SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN
0.06671 0.16628HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.10551 0.00637GU_PDEF_TARGETS_UP
0.04353 0.03158GENTILE_RESPONSE_CLUSTER_D3
0.01067 0.01549WINTER_HYPOXIA_METAGENE
0.19938 0.02401NETPATH_TNF_ALPHA_PATHWAY
0.08732 0.02185GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP
0.13273 0.01570GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.00000 0.18676REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
0.00085 0.04868TAVOR_CEBPA_TARGETS_UP
0.13594 0.16618LU_TUMOR_VASCULATURE_UP
0.00161 0.09361PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.11655 0.07319NETPATH_TNF_ALPHA_PATHWAY_UP
0.00014 0.17024KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.11885 0.04469BROWNE_HCMV_INFECTION_2HR_UP
0.18374 0.01306BILBAN_B_CLL_LPL_UP
0.01412 0.01104SESTO_RESPONSE_TO_UV_C3
0.00030 0.03598GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.00014 0.10196ZHAN_MULTIPLE_MYELOMA_DN
0.02892 0.04610NETPATH_IL_2_PATHWAY
0.01959 0.06101BIOCARTA_P38MAPK_PATHWAY
0.14941 0.12202SENESE_HDAC2_TARGETS_UP
0.13050 0.06589HADDAD_B_LYMPHOCYTE_PROGENITOR
0.00259 0.08267ROZANOV_MMP14_TARGETS_UP
0.05553 0.02658VECCHI_GASTRIC_CANCER_EARLY_UP
0.00011 0.06587LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.00045NAGASHIMA_EGF_SIGNALING_UP
0.00462 0.01300AMIT_DELAYED_EARLY_GENES
0.00020 0.03314RUGO_STRESS_RESPONSE_SUBSET_H
0.00170 0.05094RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.00340 0.17017NOJIMA_SFRP2_TARGETS_UP
0.00023 0.03124KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
0.00301 0.01878OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.00000 0.04804FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
0.02395 0.05108NCI_EPHRINBREVPATHWAY
0.00303 0.04818ZHAN_MULTIPLE_MYELOMA_HP_DN
0.00000 0.19264LEE_LIVER_CANCER_DENA_UP
0.00175 0.02527HALMOS_CEBPA_TARGETS_UP
0.00855 0.16355YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.04087 0.01441ENK_UV_RESPONSE_EPIDERMIS_UP
0.02453 0.00274NETPATH_EGFR1_PATHWAY
0.02959 0.09655ST_INTERFERON_GAMMA_PATHWAY
0.08442 0.10748REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE
0.08720 0.15502MAHADEVAN_RESPONSE_TO_MP470_DN
0.00025 0.10031HARRIS_HYPOXIA
0.15802 0.11468HUPER_BREAST_BASAL_VS_LUMINAL_DN
0.00596 0.01745KARAKAS_TGFB1_SIGNALING
0.05036 0.14306TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.01034 0.04440KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.00027 0.08229SOUCEK_MYC_TARGETS
0.12794 0.06323ENGELMANN_CANCER_PROGENITORS_DN
0.17802 0.08263SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.00005 0.05066BILBAN_B_CLL_LPL_DN
0.00002 0.06594KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.00408 0.04689IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.15815 0.15074TOMLINS_METASTASIS_DN
0.07482 0.17440GENTILE_UV_LOW_DOSE_DN
0.00000 0.08960ZHAN_MULTIPLE_MYELOMA_LB_DN
0.00101 0.02403TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.00000 0.00674RUTELLA_RESPONSE_TO_HGF_DN
0.00000 0.05921LEE_LIVER_CANCER_ACOX1_UP
0.00000 0.14178KEGG_HUNTINGTONS_DISEASE
0.04027 0.05564LEE_LIVER_CANCER_SURVIVAL_DN
0.00005 0.00737AMIT_SERUM_RESPONSE_40_MCF10A
0.00974 0.07743GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
0.06950 0.07822HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
0.18423 0.15066HOOI_ST7_TARGETS_UP
0.13245 0.01834GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.06295 0.18318HELLER_SILENCED_BY_METHYLATION_DN
0.02732 0.05057BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.00000 0.13731SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.00036 0.00297ONDER_CDH1_TARGETS_2_DN
0.13254 0.00081UDAYAKUMAR_MED1_TARGETS_DN
0.02396 0.03264SENESE_HDAC3_TARGETS_UP
0.04528 0.00782KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
0.00000 0.00112CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
0.00063 0.06148XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.00000 0.04179JISON_SICKLE_CELL_DISEASE_UP
0.00000 0.06665CORUM_55S_RIBOSOME_MITOCHONDRIAL
0.00242 0.12711KEGG_CELL_CYCLE
0.00001 0.08775XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.03956 0.09369DASU_IL6_SIGNALING_UP
0.08181 0.05773BROWNE_HCMV_INFECTION_8HR_DN
0.11431 0.03108HUPER_BREAST_BASAL_VS_LUMINAL_UP
0.00899 0.01824ZUCCHI_METASTASIS_DN
0.00007 0.01586DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
0.01564 0.08991OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP
0.06622 0.11265FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
0.00033 0.13632LINDGREN_BLADDER_CANCER_CLUSTER_1_DN